Fig. 2: Clinical efficacy. | British Journal of Cancer

Fig. 2: Clinical efficacy.

From: Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial

Fig. 2: Clinical efficacy.

a Waterfall plot of radiographic tumour regression (n = 37). Each bar represents one patient. The upper column shows clinical characteristics; TRS tumour regression grade, CR complete response, PR partial response, SD stable disease. b Disease-free survival for the surgical population (n = 37). c Overall survival for the surgical population (n = 37). mDFS median disease-free survival, mOS median overall survival.

Back to article page